<![CDATA[Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing]]>42a6ecd0-ef0b-59ea-a43c-1f22598d60e1Fri, 06 Mar 2026 20:37:51 +0000Captivate.fmDr. Neil Lovehttps://artwork.captivate.fm/e9c5ab3a-3da7-481d-91ac-e2fe510d9c76/kAB1EoauDmMGdap0qViXr5UN.jpgOncology Nursing Update with Dr Neil Love: Focus on Oncology NursingDr. Neil LoveDr. Neil LoveMedical oncologist Dr Neil Love interviews oncology experts. Free NCPD credit hours are available. https://www.researchtopractice.com/falseepisodicnopodcastOncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis - Oncology Today with Dr Neil LoveOncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis - Oncology Today with Dr Neil LoveDr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Colorado, discusses circulating tumor DNA-based molecular residual disease assessment and its current role in the management of colorectal cancer.

NCPD information and select publications here.

]]>Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Colorado, discusses circulating tumor DNA-based molecular residual disease assessment and its current role in the management of colorectal cancer.

NCPD information and select publications here.

]]>f0209fd4-8704-4865-bcf2-248663227934Fri, 06 Mar 2026 14:00:00 -050058:59falsebonusOncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease AnalysisOncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease AnalysisDr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Colorado, discusses circulating tumor DNA-based molecular residual disease assessment and its current role in the management of colorectal cancer.

NCPD information and select publications here.

]]>Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Colorado, discusses circulating tumor DNA-based molecular residual disease assessment and its current role in the management of colorectal cancer.

NCPD information and select publications here.

]]>403e1ee4-8283-4799-ac76-7f6f640881d4Fri, 06 Mar 2026 14:00:00 -050058:59falsefull25232325Follicular Lymphoma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual MeetingFollicular Lymphoma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual MeetingDr Jeremy S Abramson from Massachusetts General Hospital in Boston, Dr Jennifer Crombie from Dana-Farber Cancer Institute also in Boston and Dr Laurie H Sehn from the BC Cancer Centre for Lymphoid Cancer in Vancouver, British Columbia, Canada, discuss recent updates on available and novel treatment strategies for follicular lymphoma.  

CE information and select publications here.

]]>Dr Jeremy S Abramson from Massachusetts General Hospital in Boston, Dr Jennifer Crombie from Dana-Farber Cancer Institute also in Boston and Dr Laurie H Sehn from the BC Cancer Centre for Lymphoid Cancer in Vancouver, British Columbia, Canada, discuss recent updates on available and novel treatment strategies for follicular lymphoma.  

CE information and select publications here.

]]>a83ea4fd-c002-42a5-b12d-6ad52e9a3a5fFri, 10 Oct 2025 09:00:00 -050059:34falsefull25222225Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual MeetingRelapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual MeetingProf Meletios-Athanasios (Thanos) C Dimopoulos from Alexandra Hospital in Athens, Greece, Dr Hans Lee from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Joseph Mikhael from City of Hope Cancer Center in Phoenix, Arizona, and Dr Noopur Raje from Massachusetts General Hospital in Boston discuss recent updates on available and novel treatment strategies for relapsed/refractory multiple myeloma.  

NCPD information and select publications here.

]]>Prof Meletios-Athanasios (Thanos) C Dimopoulos from Alexandra Hospital in Athens, Greece, Dr Hans Lee from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Joseph Mikhael from City of Hope Cancer Center in Phoenix, Arizona, and Dr Noopur Raje from Massachusetts General Hospital in Boston discuss recent updates on available and novel treatment strategies for relapsed/refractory multiple myeloma.  

NCPD information and select publications here.

]]>d815eb07-0ff2-46df-9793-7f4f3ae0b9c3Thu, 02 Oct 2025 09:00:00 -050058:29falsefull25212125Multiple Myeloma — An Interview with Dr Beth Faiman on CAR T-Cell TherapyMultiple Myeloma — An Interview with Dr Beth Faiman on CAR T-Cell TherapyDr Beth Faiman from Case Comprehensive Cancer Center in Cleveland, Ohio, discusses nursing considerations with CAR T-cell therapy for patients with multiple myeloma. 

NCPD information and select publications here.

]]>Dr Beth Faiman from Case Comprehensive Cancer Center in Cleveland, Ohio, discusses nursing considerations with CAR T-cell therapy for patients with multiple myeloma. 

NCPD information and select publications here.

]]>72a485c3-3adb-4c59-9177-543ebfc0d1ddFri, 19 Sep 2025 16:00:00 -050053:08falsefull25202025Newly Diagnosed Multiple Myeloma — An Interview with Ms Charise GleasonNewly Diagnosed Multiple Myeloma — An Interview with Ms Charise GleasonMs Charise Gleason from Emory Healthcare in Atlanta, Georgia, discusses the evolution of first-line therapy for patients with multiple myeloma. 

NCPD information and select publications here.

]]>Ms Charise Gleason from Emory Healthcare in Atlanta, Georgia, discusses the evolution of first-line therapy for patients with multiple myeloma. 

NCPD information and select publications here.

]]>5fbca51d-669c-4f22-a9d5-15056e65a789Sat, 06 Sep 2025 09:00:00 -050054:17falsefull25191925Newly Diagnosed Multiple Myeloma — An Interview with Prof Xavier LeleuNewly Diagnosed Multiple Myeloma — An Interview with Prof Xavier LeleuProf Xavier Leleu from Poitiers University Hospital in Poitiers, France, discusses nursing considerations in the treatment of newly diagnosed multiple myeloma. 

NCPD information and select publications here.

]]>Prof Xavier Leleu from Poitiers University Hospital in Poitiers, France, discusses nursing considerations in the treatment of newly diagnosed multiple myeloma. 

NCPD information and select publications here.

]]>955cbd73-1e71-437c-9353-ee04c9616e05Fri, 05 Sep 2025 10:00:00 -050053:08falsefull25181825Prostate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient CareProstate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient CareMs Kathleen D Burns from City of Hope Comprehensive Cancer Center in Duarte, California, discusses nursing considerations in the care of patients with prostate cancer. 

NCPD information and select publications here.

]]>Ms Kathleen D Burns from City of Hope Comprehensive Cancer Center in Duarte, California, discusses nursing considerations in the care of patients with prostate cancer. 

NCPD information and select publications here.

]]>a88ca4ee-d6a1-4341-b423-ff88b7a81013Wed, 30 Jul 2025 15:00:00 -050044:11falsefull25171725Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New ApproachesOvarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New ApproachesMs Jennifer Filipi from the Massachusetts General Hospital Cancer Center in Boston discusses nursing considerations for the treatment of ovarian cancer. 

NCPD information and select publications here.

]]>Ms Jennifer Filipi from the Massachusetts General Hospital Cancer Center in Boston discusses nursing considerations for the treatment of ovarian cancer. 

NCPD information and select publications here.

]]>011096e4-64a3-4175-a996-e67050a1b533Fri, 18 Jul 2025 15:00:00 -050053:51falsefull25161625Chronic Lymphocytic Leukemia — Proceedings from the 2025 Annual ONS CongressChronic Lymphocytic Leukemia — Proceedings from the 2025 Annual ONS CongressDr Bita Fakhri, Dr Jeff Sharman, and nurse practitioners Dr Jacqueline Broadway-Duren and Ms Corinne Hoffman discuss the current treatment landscape for chronic lymphocytic leukemia and strategies to mitigate and manage treatment-emergent adverse events.   

NCPD information and select publications here.

]]>Dr Bita Fakhri, Dr Jeff Sharman, and nurse practitioners Dr Jacqueline Broadway-Duren and Ms Corinne Hoffman discuss the current treatment landscape for chronic lymphocytic leukemia and strategies to mitigate and manage treatment-emergent adverse events.   

NCPD information and select publications here.

]]>d83235a7-b810-4cd9-bc3a-b83a67f5bbbbFri, 11 Jul 2025 08:00:00 -050001:30:22falsefull25151525DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer — Proceedings from the 2025 Annual ONS CongressDLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer — Proceedings from the 2025 Annual ONS CongressDr Anne Chiang, Dr Erin Schenk, and nurse practitioners Ms Elizabeth Krueger and Ms Beth Sandy discuss the role of bispecific antibodies in the management of small cell lung cancer and strategies to mitigate and manage treatment-emergent adverse events. 

NCPD information and select publications here.

]]>Dr Anne Chiang, Dr Erin Schenk, and nurse practitioners Ms Elizabeth Krueger and Ms Beth Sandy discuss the role of bispecific antibodies in the management of small cell lung cancer and strategies to mitigate and manage treatment-emergent adverse events. 

NCPD information and select publications here.

]]>d8bb03e4-36ed-4d61-9e4a-b956daee6f4cMon, 07 Jul 2025 16:00:00 -050001:27:39falsefull25141425Non-Hodgkin Lymphoma — Proceedings from the 2025 Annual ONS CongressNon-Hodgkin Lymphoma — Proceedings from the 2025 Annual ONS CongressDr Christopher Flowers and Dr Manali Kamdar summarize the clinical treatment landscape for patients with non-Hodgkin lymphoma, supported by clinical perspectives and management strategies from nurse practitioners Ms Robin Klebig and Ms Caitlin Murphy. 

NCPD information and select publications here.

]]>Dr Christopher Flowers and Dr Manali Kamdar summarize the clinical treatment landscape for patients with non-Hodgkin lymphoma, supported by clinical perspectives and management strategies from nurse practitioners Ms Robin Klebig and Ms Caitlin Murphy. 

NCPD information and select publications here.

]]>1f1fd847-1646-4646-9a0d-95a6dd8c6c13Fri, 04 Jul 2025 09:00:00 -050001:26:53falsefull25131325Chronic Myeloid Leukemia — Proceedings from the 2025 Annual ONS CongressChronic Myeloid Leukemia — Proceedings from the 2025 Annual ONS CongressDr Michael Mauro, Dr Neil Shah, and nurse practitioners Ms Ilene Galinsky and Dr Sara Tinsley-Vance discuss important nursing considerations in the modern treatment of chronic myeloid leukemia. 

NCPD information and select publications here.

]]>Dr Michael Mauro, Dr Neil Shah, and nurse practitioners Ms Ilene Galinsky and Dr Sara Tinsley-Vance discuss important nursing considerations in the modern treatment of chronic myeloid leukemia. 

NCPD information and select publications here.

]]>fd453984-6e6e-4640-a877-e77da37ca9bdFri, 27 Jun 2025 13:00:00 -050001:26:22falsefull25121225Hormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS CongressHormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS CongressDrs Virginia F Borges and Seth Wander summarize the treatment landscape for patients with hormone receptor-positive breast cancer, supported with clinical perspectives and management strategies from nurse practitioners Ms Jamie Carroll and Mr Ronald Stein. 

NCPD information and select publications here.

]]>Drs Virginia F Borges and Seth Wander summarize the treatment landscape for patients with hormone receptor-positive breast cancer, supported with clinical perspectives and management strategies from nurse practitioners Ms Jamie Carroll and Mr Ronald Stein. 

NCPD information and select publications here.

]]>6f0e53f5-9663-4347-9e7f-203903e44257Mon, 16 Jun 2025 09:00:00 -050001:54:49falsefull25111125Gastroesophageal Cancer — Proceedings from the 2025 Annual ONS CongressGastroesophageal Cancer — Proceedings from the 2025 Annual ONS CongressDr Sunnie Kim and Dr Manish Shah summarize the clinical treatment landscape for patients with gastroesophageal cancers, supported by clinical perspectives and management strategies from oncology nursing experts Ms Brooke Parker and Ms Michal Segal. 

NCPD information and select publications here.

]]>Dr Sunnie Kim and Dr Manish Shah summarize the clinical treatment landscape for patients with gastroesophageal cancers, supported by clinical perspectives and management strategies from oncology nursing experts Ms Brooke Parker and Ms Michal Segal. 

NCPD information and select publications here.

]]>202df0d6-d3a7-43e6-8b28-79f802b05883Thu, 12 Jun 2025 09:00:00 -050001:29:49falsefull25101025Endometrial Cancer — Proceedings from the 2025 Annual ONS CongressEndometrial Cancer — Proceedings from the 2025 Annual ONS CongressDr Ritu Salani and Dr Brian Slomovitz and nurse practitioners Ms Kathryn Lyle and Ms Jaclyn Shaver discuss datasets guiding treatment decision-making for patients with endometrial cancer and strategies to mitigate and manage treatment-emergent adverse events. 

NCPD information and select publications here.

]]>Dr Ritu Salani and Dr Brian Slomovitz and nurse practitioners Ms Kathryn Lyle and Ms Jaclyn Shaver discuss datasets guiding treatment decision-making for patients with endometrial cancer and strategies to mitigate and manage treatment-emergent adverse events. 

NCPD information and select publications here.

]]>5e1eef36-e118-45d8-881d-465cae68e4a5Fri, 06 Jun 2025 14:00:00 -050001:28:47falsefull259925Pancreatic Cancer — Proceedings from the 2025 Annual ONS CongressPancreatic Cancer — Proceedings from the 2025 Annual ONS CongressDrs Farshid Dayyani and Philip A Philip and oncology nursing professionals Caroline Kuhlman and Amanda K Wagner discuss datasets guiding treatment decision-making for patients with metastatic pancreatic cancer and strategies to mitigate and manage treatment-emergent adverse events.  

NCPD information and select publications here.

]]>Drs Farshid Dayyani and Philip A Philip and oncology nursing professionals Caroline Kuhlman and Amanda K Wagner discuss datasets guiding treatment decision-making for patients with metastatic pancreatic cancer and strategies to mitigate and manage treatment-emergent adverse events.  

NCPD information and select publications here.

]]>6aa3ac84-e460-4a2d-99b7-0740e8e29608Fri, 30 May 2025 16:00:00 -050001:33:16falsefull258825Prostate Cancer — Proceedings from the 2025 Annual ONS CongressProstate Cancer — Proceedings from the 2025 Annual ONS CongressDr Rahul Aggarwal and Dr William K Oh and nurse practitioners Ms Monica Averia and Ms Kathleen D Burns discuss the current treatment landscape for prostate cancer and protocols to mitigate and manage treatment-emergent adverse events. 

NCPD information and select publications here.

]]>Dr Rahul Aggarwal and Dr William K Oh and nurse practitioners Ms Monica Averia and Ms Kathleen D Burns discuss the current treatment landscape for prostate cancer and protocols to mitigate and manage treatment-emergent adverse events. 

NCPD information and select publications here.

]]>eb89fd8f-f098-4c75-b776-d16e4aa80b0cThu, 08 May 2025 09:00:00 -050001:27:51falsefull257725Ovarian Cancer — Proceedings from the 2025 Annual ONS CongressOvarian Cancer — Proceedings from the 2025 Annual ONS CongressDr David O’Malley and Dr Shannon Westin summarize the clinical treatment landscape for ovarian cancers, supported by clinical perspectives and management strategies from nurse practitioners Ms Courtney Arn and Ms Jennifer Filipi. 

NCPD information and select publications here.

]]>Dr David O’Malley and Dr Shannon Westin summarize the clinical treatment landscape for ovarian cancers, supported by clinical perspectives and management strategies from nurse practitioners Ms Courtney Arn and Ms Jennifer Filipi. 

NCPD information and select publications here.

]]>7b8161df-e989-44ca-b4aa-95967bbb147cThu, 01 May 2025 09:00:00 -050001:29:57falsefull256625Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS CongressAntibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS CongressDr Edward B Garon, Dr Tiffany A Traina, and nurse practitioners Ms Marianne J Davies and Ms Marissa Marti-Smith discuss the role of antibody-drug conjugates in the care of patients with breast and lung cancer and strategies to mitigate and manage treatment-emergent adverse events. 

NCPD information and select publications here.

]]>Dr Edward B Garon, Dr Tiffany A Traina, and nurse practitioners Ms Marianne J Davies and Ms Marissa Marti-Smith discuss the role of antibody-drug conjugates in the care of patients with breast and lung cancer and strategies to mitigate and manage treatment-emergent adverse events. 

NCPD information and select publications here.

]]>e29fffc8-4d3b-4c79-b423-11985206caaaSat, 26 Apr 2025 09:00:00 -050001:29:57falsefull254425Special 2-Part Edition for Oncology Nurses: Bispecific Antibodies in Lymphoma — Part 2Special 2-Part Edition for Oncology Nurses: Bispecific Antibodies in Lymphoma — Part 2Nurse practitioner Ms Amy Goodrich from The Sidney Kimmel Comprehensive Care Center in Baltimore, Maryland, presents cases from her practice illustrating the efficacy and safety of bispecific antibodies for non-Hodkin lymphoma. 

NCPD information and select publications here.

]]>Nurse practitioner Ms Amy Goodrich from The Sidney Kimmel Comprehensive Care Center in Baltimore, Maryland, presents cases from her practice illustrating the efficacy and safety of bispecific antibodies for non-Hodkin lymphoma. 

NCPD information and select publications here.

]]>19ea2d63-84e8-4b03-b593-75b64ab1d4a2Fri, 18 Apr 2025 09:00:00 -050058:21falsefull253325Special 2-Part Edition for Oncology Nurses: Bispecific Antibodies in Lymphoma — Part 1Special 2-Part Edition for Oncology Nurses: Bispecific Antibodies in Lymphoma — Part 1Ms Robin Klebig from the Mayo Clinic in Rochester, Minnesota, discusses the emerging role of bispecific antibodies in the treatment of non-Hodgkin lymphoma. 

NCPD information and select publications here.

]]>Ms Robin Klebig from the Mayo Clinic in Rochester, Minnesota, discusses the emerging role of bispecific antibodies in the treatment of non-Hodgkin lymphoma. 

NCPD information and select publications here.

]]>3386eeb6-bdab-445d-a936-5c2f7c844b0fMon, 07 Apr 2025 09:00:00 -050001:05:59falsefull252225Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards for Oncology NursesBispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards for Oncology NursesDr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.

NCPD information and select publications here.

]]>Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.

NCPD information and select publications here.

]]>5d279890-7057-476d-8725-f5492b36642bSun, 06 Apr 2025 09:00:00 -050001:05:16falsefull251125